CGNX stock closed at $51.25, down 3.61% on 05 Mar 2026, after profit-taking and mixed signals on near-term demand. We focus on how Cognex Corporation (CGNX) is leaning into OneVision and SLX AI products to expand industrial machine vision use cases. The stock trades on NASDAQ in the United States with volume 1,533,933 shares and a market cap of $8,492,530,900.00. Key short-term metrics: EPS 0.68 and P/E 75.37. As an AI stocks specialist, we put product cadence, margins, and analyst targets at the center of the CGNX stock outlook

CGNX stock: Price action and technicals

Today CGNX stock fell 3.61% to $51.25, reversing intraday highs near $53.72 and hitting a low of $50.59. The move came on volume 1,533,933, below the 30‑day average, signaling a measured pullback rather than a panic sell.

Technically, the RSI sits near 52.61, ADX reads 35.90 indicating a strong trend, and the MACD histogram is negative. These indicators suggest short-term momentum cooled after the recent run, while the 50‑day average $43.91 and 200‑day average $39.99 still support a medium-term uptrend

CGNX stock: Fundamentals and valuation

Cognex reported trailing EPS 0.68 and a trailing P/E of 75.37, reflecting growth expectations priced into the shares. Revenue per share is 5.95 and book value per share is 8.92, producing a P/B near 5.73.

Balance-sheet strength is notable: current ratio 3.80, cash per share 2.01, and net debt to EBITDA negative. Free cash flow yield is about 2.80% and payout ratio is 47.73% after the $0.085 quarterly dividend. Valuation compares steeply to peers, so CGNX stock depends on continued margin expansion and AI-driven mix improvement

CGNX stock: AI products and growth drivers

Cognex is pushing OneVision and SLX to make AI vision easier and repeatable across sites. OneVision is cloud‑enabled and targets faster rollouts and cross‑site performance, which can shorten pilot cycles and lift enterprise penetration.

Embedded AI in DataMan 290 and In‑Sight 8900 expands edge use cases. If these products drive higher mix and pricing, management expects through‑cycle adjusted EBITDA margins of 25.00% to 31.00%, with a 25.00% run‑rate goal exiting 2026

CGNX stock: Analysts, ownership and catalysts

Wall Street shows mixed but mostly constructive views. Consensus price target is $55.21; top targets include UBS $70.00, Goldman Sachs $68.00, Needham $67.00, and DA Davidson $55.00. Insider selling has been notable, with 196,083 shares sold recently. Institutional ownership stands about 88.12%, concentrating influence among funds.

Key catalysts for CGNX stock are OneVision adoption, SLX logistics traction, semiconductor spending later in 2026, and margin savings from the planned $35.00–$40.00 million cost program

CGNX stock: Meyka AI rates CGNX and forecast

Meyka AI rates CGNX with a score out of 100: 73.03 (Grade B+, Suggestion: BUY). This grade factors S&P 500 and sector comparisons, financial growth, key metrics, analyst consensus, and forecasts. This grade is informational and not financial advice.

Meyka AI’s forecast model projects monthly $47.56, quarterly $45.80, and yearly $33.96. Versus the current price $51.25, that implies short‑term downside of -7.20% to the monthly figure, -10.63% to the quarterly figure, and -33.74% to the yearly figure. Forecasts are model‑based projections and not guarantees

CGNX stock: Risks and outlook

Risk factors for CGNX stock include quarter‑to‑quarter book‑to‑ship volatility, slower logistics growth than expected, and execution risk on cross‑site AI deployments. A high trailing P/E 75.37 makes the stock sensitive to earnings misses.

On the upside, durable margin improvement, broader SLX adoption in logistics, and embedded AI wins in consumer electronics or automotive could re‑rate the shares toward analyst targets near $67.00–$70.00

Final Thoughts

CGNX stock closed $51.25 on 05 Mar 2026 after a modest pullback. The core takeaway: Cognex is shifting from a single‑market surge to platform‑led expansion with OneVision and SLX. That strategy can lift repeatable deployments and mix quality, supporting management’s target of 25.00% adjusted EBITDA. Analysts offer a range of targets from $55.21 consensus to top calls near $70.00. Meyka AI’s forecast model projects a near‑term monthly level of $47.56 (implied -7.20%), and a one‑year projection of $33.96 (implied -33.74%) versus today’s price of $51.25. These model outputs show downside risk if execution slows, but upside exists if OneVision adoption accelerates and margin actions deliver. We note EPS 0.68, P/E 75.37, market cap $8,492,530,900.00, and the next earnings date 29 Apr 2026. Use this analysis with your own research; Meyka AI is an AI‑powered market analysis platform providing data‑led context, not investment advice

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.